Harvard Drug Group LLC adds Watson Pharmaceuticals Inc.’sRugby Laboratories Inc.OTC business to its expanding lineup of properties in a $117 million deal announced Oct. 29.
Harvard Drug Continues Expansion With Watson’s Rugby OTC Business
Watson Pharmaceuticals sells OTC business Rugby Laboratories to Harvard Drug Group, which operates Major Pharmaceuticals manufacturing. Watson divests a business that accounted for a small part of the private label OTC market, but keeps its pending ANDAs for guaifenesin expectorants and its smoking-cessation generics.